Skip to main content

CAR T-Cell Therapy - Treatment of Various Hematological Malignancies

 

CAR T-cell (Chimeric Antigen Receptor T-cell) therapy is used predominantly in the treatment of various hematological malignancies (HMs), such as acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), lymphoma (diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, mantle cell lymphoma), and multiple myeloma (MM). HMs are blood cancers caused due to the uncontrolled growth of lymphoid and hematopoietic tissues (bone marrow). HMs are clinically and biologically heterogeneous disorders responsible for nearly 6.5% of all cancers across the globe, around 9.0% of cancers in the U.S. and Europe collectively. According to the estimates provided by Global Cancer Observatory (Globocan), an international agency for research on cancer, the total number of prevalent cases of hematologic malignancies in the world was 2,903,711 in 2018. The U.S. contributed around 15% of global prevalent cases of hematologic malignancies, and China contributed around 17% of total cases in 2018. As per the data published by the Leukemia and Lymphoma Society, in the U.S., approximately one person is diagnosed with hematologic cancer every three minutes. It is also estimated that by the end of 2020, the incidence of leukemia, lymphoma, or myeloma in the U.S. will reach 178,520 cases.

View BIS Report CAR T-Cell Therapy Market

About BIS Research

BIS Research, a premium market intelligence company offers in-depth insights and consulting to Fortune 500 companies. We are established and known for tracking the growth of deep technologies across key industry verticals and the subsequent challenges and opportunities associated with deep tech across markets, applications and products.

 

With more than 500 clients, over 7000 plus primary interviews and approximately 200 reports published in a year BIS Research has set an interesting growth trajectory for itself. We provide market estimations, emerging high-growth applications, technology analysis, highly segmented granular country-level market data, and other important market parameters that come in handy for our clients during strategic decision-making.

We publish a wide gamut of syndicated market studies across industry verticals. In addition, bespoke market studies is another area where BIS Research excels at along with consulting services.

Labels:

Comments

Post a Comment

Popular posts from this blog

Farm Management Software and Data Analytics Market Future Prospects And Competitive Analysis 2020-2026

The growth in the global farm management software and data analytics market is expected to be driven by increasing demand for agricultural mechanization and automation along with increasing average farm size in certain countries such as Australia and Canada. Report Preview is available at: https://bisresearch.com/industry-report/global-farm-management-software-data-analytics-market.html Farm management software and data analytic solutions not only offer increased transparency in the agricultural field but also decrease the chances of pest attack and crop failure. Increased agricultural production will help in catering to the growing population and uplifting the global agricultural industry. A major factor driving the farm management software and data analytics market is the increase in government initiatives and support toward agricultural digitization. Government initiatives increase the awareness regarding the farm management software and the benefits these solutions entail when appl...
Post a Comment
Read more

Intelligent Lighting Controls Market Report

The report constitutes an extensive study of intelligent lighting controls market. It includes a thorough analysis of different component types as well as different connection types used in the intelligent lighting controls. Intelligent lighting controls market has further been segmented in terms of application which helps in understanding the behavior of different verticals in using intelligent lighting controls. It further explains the driving forces, challenges and growth opportunities of the intelligent lighting controls market. Major players have been identified on the basis of revenue generation, geographical presence and developments related to intelligent lighting controls. A detailed company profiling has been done in order to understand the player’s strategic behavior. The intelligent lighting controls market is further explained and analyzed on the basis of geography. The geographical analysis has been categorized into four regions namely: North America, Europe, Asia-Pa...
Post a Comment
Read more

Liquid Biopsy, North America, and Lung Cancer Occupying a Major Share in the Market

  Owing to the market availability of large number of liquid biopsy technologies, the liquid biopsy segment currently accounts for a dominating share in the global minimally invasive biopsy technologies market . However, the market growth in the segment can be attributed to the increasing demand for liquid biopsy and the strong product pipeline. For instance, CNI Second Opinion by Chronix Biomedical is presently under development and is expected to get launched during the forecast period 2019-2030. Owing to a widespread market presence of leading players and the huge prevalence of cancer, North America presently holds a major share in the global minimally invasive biopsy technologies market. According to the World Cancer Research Fund (WCRF), with an estimated 2 million cases in 2018, lung cancer is the most commonly occurring cancer in men and third-most commonly occurring cancer in women. Due to the widespread presence of cancer, the manufacturers including Biocept, Inc., Chron...
Post a Comment
Read more